,,ii  #aagth ,,congress  #ast ,session  
,s4 #bjbe  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #aj1     
#bjba,mr4 ,cornyn 7for himself1 ,ms4    
,sinema1 ,mrs4 ,hyde-,smith1 and ,mr4   
,carper7 introduced the following bill2 
which was read twice and referred to the
 ,committee on ,finance  ,a ,,bill  ,to 
amend title ,,xviii of the ,social      
,security ,act to improve access to     
innovative new medical devices furnished
 to individuals with end stage renal    
disease under part ,b of the ,medicare  
program by establishing a new device    
add-on payment adjustment under such    
part4  #a4 ,short title ,this ,act may  
be cited as the ,patient ,access to     
,,esrd ,new ,innovative ,devices ,act4  
#b4 ,findings ,congress finds the       
following3 7#a7 ,there are approximately
 #djj1jjj ,medicare beneficiaries with  
end-stage renal disease1 making up #a   
percent of the ,medicare population but 
accounting for approximately #g percent 
of all ,medicare spending4  7#b7        

,expected remaining lifetime for        
dialysis patients under #hj years old is
 one-third as long as their counterparts
 without ,,esrd1 and for dialysis       
patients over #hj years old1 it is      
one-half as long as that of their       
counterparts without ,,esrd4  7#c7 ,on  
average1 hemodialysis patients are      
hospitalized nearly twice per year and  
about #cj percent have an unplanned     
rehospitalization within the #cj days   
following discharge1 contributing to    
high costs for treating ,,esrd ,medicare
 beneficiaries4  7#d7 ,there is a lack  
of innovative new devices for ,,esrd    
,medicare beneficiaries1 in part because
 of the lack of reimbursement incentives
 for novel devices4  #c4 ,increasing    
patient access to innovative devices for
 the treatment of ,,esrd ,the ,secretary
 of ,health and ,human ,services shall  
provide1 and may implement by program   
instruction or otherwise-- 7#a7 a       
#c-year temporary add-on payment        
adjustment under section #ahha7;b77#ad7 

of the ,social ,security ,act 7#db      
,u4,s4 #acierr7b77#ad77 for a new       
medical device approved by the ,food and
 ,drug ,administration under section    
#eac7;f77#b7 of the ,federal ,food1     
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cfj;c7 on or after ,january #a1 #bjbj1
 that is furnished to a beneficiary for 
the diagnosis1 treatment1 or management 
of end stage renal disease2 and  7#b7   
for such adjustment to be implemented in
 a nonbudget neutral manner under such  
section #ahha7;b77#ad74